Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. Chemotherapy. University of North Carolina, Chapel Hill, N.C., United States

Survival: 6.5 months
Toxicity Grade: 5
Treatments: Biologic therapy
Drugs: Taxotere
Country: United States
City/State/Province: Chapel Hill, N.C.
Hospital: University of North Carolina
Journal: Link
Date: 6/2006

Patients: This Phase I/II trial involved a total of 26 patients with advanced non-small-cell lung cancer. There were 17 men and 9 women. The median age was 75.5.

Treatment: The treatment consisted of the chemotherapy drug Docetaxel and the biological therapy Gefitinib (Iressa) that inhibits an enzyme (tyrosine kinase).

Toxicity: There was one grade 5 pulmonary toxicity. Grade 3-4 toxicities included hematologic, gastrointestinal, dermatological, and infection.

Results: The median overall survival was 6.5 months.

Correspondence: Thomas E. Stinchcombe

E-mail to a Friend Email Physician More Information